Method evaluation of pepsinogen I/II assay based on chemiluminescent immunoassays and comparison with other test methods

The overall analytical performance of Architect Pepsinogen I/II assay is acceptable for the detection of patients with suspected AG. The categorization results of gastric cancer risk showed some difference among test methods suggesting the need for harmonization among the methods from vendors.